1-17 of 17
Francois Xavier Gros
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hemophagocytic Lymphohistiocytosis-like Syndrome after Anti-CD19 CAR T-Cells for B-Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Lysa, Sfce and Graall Study from the Descar-T Registry

Nicolas Gower, Cécile Pizot, Marie-Emilie Dourthe, Thomas Gastinne, Gabriel Brisou, Stephanie Guidez, Jean-Jacques Tudesq, Adrien Chauchet, Laura Herbreteau, Arnaud Campidelli, Pierre Sesques, Edmond Chiche, Francois Xavier Gros, Amandine Durand, Marion Lubnau, Arthur Sterin, Roberta Di Blasi, Jacques-Olivier Bay, Alexandra Marquet, Elodie Gat, Roch Houot, Franck Morschhauser, Jérôme Paillassa
Journal: Blood
Blood (2024) 144 (Supplement 1): 528.
https://doi.org/10.1182/blood-2024-208304
Published: 2024
Journal Articles

Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma

Catherine Thieblemont, François-Xavier Gros, Sandrine Roulland, Salim Kanoun, Veronique Meignin, Celine Row, Thierry Lamy, Emmanuel Gomez, Karin Tarte, Gabriel Brisou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7226.
https://doi.org/10.1182/blood-2024-207843
Published: 2024
Journal Articles

Health-Related Quality of Life after Axi-Cel As a Second-Line Therapy in Patients with High-Risk Relapsed/Refractory Large B-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Results of the Alycante Phase II Trial

Emilie Charton, Amelie Anota, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Remy Dulery, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques-Olivier Bay, Francesco Llamas Gutierrez, Cédric Portugues, Emmanuel Itti, Xavier Pallard, Paul Blanc-Durand, Yassine Al Tabaa, Clément Bailly, Camille Laurent, Francois Lemonnier, Roch Houot
Journal: Blood
Blood (2024) 144 (Supplement 1): 4505.
https://doi.org/10.1182/blood-2024-200614
Published: 2024
Journal Articles

Allogeneic Stem-Cell Transplantation for Relapsed/Refractory ALK-Positive Anaplastic Large-Cell Lymphoma: A Study from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Thomas Grange, Jean-Philippe Jais, Flore Sicre de Fontbrune, Cristina Castilla-Llorente, Ambroise Marçais, Herve Ghesquieres, Raynier Devillier, Ibrahim Yakoub-Agha, Karin Bilger, François-Xavier Gros, Natacha Maillard, Anne Huynh, Jean-Baptiste Méar, Marie-Thérèse Rubio, Johan Maertens, Patrice Chevallier, Fanny Rialland Battisti, Sylvie François, Claude-Éric Bulabois, Alban Villate, Michael Loschi, Cécile Renard, Amandine Charbonnier, Bénédicte Bruno, Jacques-Olivier Bay, Christine Devalck, Jérome Cornillon, Xavier Poiré, Arthur Sterin, Ludovic Gabellier, Nicole Raus, Stéphanie Nguyen-Quoc, Charlotte Rigaud, David Sibon
Journal: Blood
Blood (2024) 144 (Supplement 1): 4946.
https://doi.org/10.1182/blood-2024-212055
Published: 2024
Journal Articles

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

Clinical Trials & Observations
Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensaber, Morgane Cheminant, Caroline Jacquet, Stéphanie Guidez, François-Xavier Gros, Emmanuel Bachy, Arthur Coste, Pascale Cony-Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2024) 143 (26): 2804–2807.
https://doi.org/10.1182/blood.2024024452
Published: 2024
Includes: Supplemental data
Journal Articles

CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study

Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensader, Morgane Cheminant, Caroline Jacquet, Stephanie Guidez, François-Xavier Gros, Emmanuel Bachy, Pascale Cony-Makhoul, Steven P Treon, Alain Jacques Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 616.
https://doi.org/10.1182/blood-2023-173988
Published: 2023
Journal Articles

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Pierre Sesques, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loic Ysebaert, Fabrice Jardin, Choquet Sylvain, Jacques-Olivier Bay, Francois Xavier Gros, Franck Morschhauser, Olivier Casasnovas, Thomas Gastinne, Catherine Thieblemont, Magalie Joris, Laure Ricard, Caroline Regny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marcais, Karin Tarte, Camille Laurent, Guillaume Cartron
Journal: Blood
Blood (2023) 142 (Supplement 1): 893.
https://doi.org/10.1182/blood-2023-177703
Published: 2023
Journal Articles

Outcomes of High-Grade B-Cell Lymphoma As Compared to Other Large B-Cell Lymphoma Subtypes in Patients Treated with CD19-Directed CAR-T Cells at 3 rd Line or More. a Lysa Study Based on the French Descart-Registry.

Xavier Phina-Ziebin, Emmanuel Bachy, Francois Xavier Gros, Roberta Di Blasi, Charles Herbaux, Jacques-Olivier Bay, Sylvain Carras, Pierre Bories, René-Olivier Casasnovas, Fabrice Jardin, Franck Morschhauser, Blandine Guffroy, Elodie Gat, Julien Calvani, Marie Parrens, Elsa Poullot, Alexandra Traverse-Glehen, Louise Roulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3112.
https://doi.org/10.1182/blood-2023-180707
Published: 2023
Journal Articles

Verlen, “Very Elderly Rituximab Associated to Lenalidomide - Tafasitamab Combination in Frontline DLBCL Patients”, a Phase II Open-Label Study Evaluating Efficacy of Lenalinomide and Tafasitamab Combination Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older from the Lysa Group

Benoit Tessoulin, Julien Depaus, Pierre Feugier, Ludovic Fouillet, Julie Abraham, Sandy Amorin, Fabrice Jardin, Franck Morschhauser, Catherine Thieblemont, François-Xavier Gros, Bertrand Joly, Hacene Zerazhi, Sophie Bernard, Adrien Chauchet, Stéphane Vigouroux, Christophe Bonnet, Sarah Bailly, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 3094.
https://doi.org/10.1182/blood-2023-173265
Published: 2023
Journal Articles

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry

Gabriel Brisou, Guillaume Cartron, Emmanuel Bachy, Catherine Thieblemont, Cristina Castilla-Llorente, Fabien Le Bras, François-Xavier Gros, Michael Loschi, Roch Houot, Remy Dulery, Fabrice Jardin, Magalie Joris, Choquet Sylvain, Franck Morschhauser, Stephanie Guidez, Olivier Hermine, Laurianne Drieu La Rochelle, Sylvain Carras, Blandine Guffroy, Pierre Bories, Rene-Olivier Casasnovas, Julie Abraham, Steven Le Gouill, Pascale Cony-Makhoul, Elodie Gat, Benoit Tessoulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 5138.
https://doi.org/10.1182/blood-2023-180241
Published: 2023
Journal Articles

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

CME Clinical Trials & Observations
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Olivier Casasnovas, Jacques Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Journal: Blood
Blood (2022) 140 (24): 2584–2593.
https://doi.org/10.1182/blood.2022016945
Published: 2022
Journal Articles

Late Failure of Aggressive B-Cell Lymphoma Following CAR T-Cell Therapy: A Lysa Study from the Descar-T Registry

Federico Erbella, Emmanuel Bachy, Guillaume Cartron, Elodie Gat, Franck Morschhauser, Benoit Tessoulin, Olivier Tournilhac, Choquet Sylvain, François-Xavier Gros, Cristina Castilla-Llorente, Arnaud Campidelli, René-Olivier Casasnovas, Louise Roulin, Pierre Bories, Mohamad Mohty, Martin Carre, Steven Le Gouill, Roch Houot, Roberta Di Blasi
Journal: Blood
Blood (2022) 140 (Supplement 1): 1325–1327.
https://doi.org/10.1182/blood-2022-165352
Published: 2022
Journal Articles

Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study

Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Remy Dulery, Catherine Thieblemont, Magalie Joris, Francisco Llamas-Gutierrez, Emmanuel Itti, Cedric Menard, Yassine Al-Tabaa, Clement Bailly, Marie-Helene Delfau, Camille Laurent, Francois Lemonnier
Journal: Blood
Blood (2022) 140 (Supplement 1): 410–411.
https://doi.org/10.1182/blood-2022-156626
Published: 2022
Journal Articles

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry

Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, Francois Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Rene-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Journal: Blood
Blood (2021) 138 (Supplement 1): 885.
https://doi.org/10.1182/blood-2021-150994
Published: 2021
Journal Articles

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Cartron, David Beauvais, Louise Roulin, Francois Xavier Gros, Choquet Sylvain, Pierre Bories, Marie Thérèse Rubio, Rene-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Jean Jacques Tudesq, Isabelle Chaillol, Florence Broussais, Catherine Thieblemont, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2021) 138 (Supplement 1): 92.
https://doi.org/10.1182/blood-2021-150721
Published: 2021
Journal Articles

Feasibility and Outcome of Late Intensification with Native L-Asparaginase for Acute Lymphoblastic Leukemia in the Elderly: A Single Center Experience

Francois Xavier Gros, MD, Pierre-Yves Dumas, MD, Edouard Forcade, MD, Claire Calmettes, MD, Margot Robles, MD, Vincent Servant, PharmD, Nicolas Lechevalier, PharmD, Audrey Bidet, PharmD, Noel Milpied, Arnaud Pigneux, MD PhD, Thibaut Leguay, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1296.
https://doi.org/10.1182/blood.V130.Suppl_1.1296.1296
Published: 2017
Journal Articles

Improved Outcome with a Pediatric-Inspired Regimen for Philadelphia-Negative Acute Lymphoblastic Leukemia in the Elderly

Francois Xavier Gros, MD, Pierre-Yves Dumas, MD, Edouard Forcade, MD, Claire Calmettes, MD, Margot Robles, MD, Vincent Servant, PharmD, Nicolas Lechevalier, PharmD, Audrey Bidet, PharmD, Noel Milpied, Arnaud Pigneux, MD PhD, Thibaut Leguay, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2560.
https://doi.org/10.1182/blood.V130.Suppl_1.2560.2560
Published: 2017